Diasorin | DIA - Operating Expenses


Diasorin reported EUR224.05M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amplifon EUR 539.04M 16.22M Sep/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Brookdale Senior Living USD 726.71M 733.44M Dec/2025
Cencora USD 84.92B 2.15B Dec/2025
Diasorin EUR 224.05M 6.89M Sep/2025
Encompass Health USD 1.26B 27.3M Dec/2025
Enovis USD 573.32M 532.17M Dec/2025
GE HealthCare Technologies USD 4.82B 408M Dec/2025
OPKO Health USD 186.77M 18.42M Dec/2025
Pediatrix Medical Group USD 439.1M 20.23M Dec/2025
Veradigm USD 188M 61.08M Dec/2022
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025